MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Evaluation of Motor Function Using Motor Testing App and Deep Learning for the Treatment of Lewy Body Dementia

    X. Dang, Y. Guan, K. Deng, J. Wang, H. Zhang, C. Battioui, M. Pugh, B. Winger, J. Yang, K. Biglan (Cambridge, USA)

    Objective: To construct deep learning (DL) models using finger tapping data and apply them in PRESENCE to evaluate treatment effect in motor function. Background: PRESENCE…
  • MDS Virtual Congress 2021

    Re-thinking enrollment of Deep Brain Stimulation patients in Parkinson’s Disease Clinical Trials

    J. Jimenez-Shahed, J. Rosenow, S. Miocinovic, L. Luo, C. Aquino, D. Corcos, P. Agarwal (New York, USA)

    Objective: To report on a survey of Parkinson’s disease (PD) experts on the inclusion of PD patients with deep brain stimulation (DBS) in clinical trials.…
  • MDS Virtual Congress 2021

    Parkinson Progression Marker Initiative – New Science/New Cohorts

    K. Marek, A. Siderowf, T. Simuni, L. Chahine, K. Kieburtz, B. Mollenhauer, D. Galasko, K. Merchant, E. Brown, C. Coffey, R. Dobkin, T. Foroud, K. Poston, E. Flagg, S. Chowdhury, C. Tanner (New Haven, USA)

    Objective: The Parkinson Progression Marker Initiative (PPMI) is expanding its cohorts and exploring additional biomarkers of PD progression to test hypotheses of the underlying molecular…
  • MDS Virtual Congress 2021

    Impact of specialized light therapy in Parkinson’s disease on MDS-UPDRS parts 1-3 subscales

    B. Wyman, S. Hendrix, S. Hennessey, S. Dickson, J. Groves, W. Croft, D. Adams (Draper, USA)

    Objective: An exploratory analysis to examine the MDS-UPDRS 1-3 subitems of PD patients who underwent specialized light therapy (SLT) to assess the breadth of impact…
  • MDS Virtual Congress 2021

    Safety, tolerability and CNS effects after single and multiple doses of β-agonists in healthy volunteers and patients with Parkinson’s disease

    P. Eijsvogel, S. Prins, L. Moss, L. Borghans, B. van Kraaij, E. van Brummelen, E. Klaassen, R. Martin, E. Bautista, A. Ford, GJ. Groeneveld, G. Vargas (Leiden, Netherlands)

    Objective: This study aimed to assess the effects of β-agonists on central nervous system (CNS) functioning in healthy volunteers and patients with Parkinson’s disease. Background:…
  • MDS Virtual Congress 2021

    Effects of Once-Daily Opicapone 50 mg on the Pharmacokinetics of Levodopa Administered as Carbidopa/Levodopa Extended-Release Capsules: An Open-Label Phase 1 Study

    G. Loewen, A. Vijan, K. Olson, T. O’Reilly, G. Liang, O. Klepitskaya (San Diego, USA)

    Objective: To assess the effects of opicapone 50 mg on the pharmacokinetics (PK) of levodopa (LD) and its metabolite, 3-O-methyldopa (3-OMD), when administered with oral…
  • MDS Virtual Congress 2021

    Community-Based Multidisciplinary Program for People with Parkinson Disease: A 2-year comparison

    S. Parveen, T. Passmore, B. Brickell, S. Jackson (Stillwater, USA)

    Objective: The current study reports outcomes from a 2 year-long community-based multidisciplinary program for individuals with Parkinson disease (PD) and their families based in Oklahoma…
  • MDS Virtual Congress 2021

    Local Field Potentials (LFP) used to guide treatment of biphasic dyskinesias in a patient with Parkinson’s Disease (PD)

    O. Vaou, C. Harrington, S. Stanslaski, R. Cosgrove, A. Depold Hohler (Brighton, USA)

    Objective: To identify, characterize and treat dyskinesias and off time in a patient with PD via the use of gamma and beta peak LFP using…
  • MDS Virtual Congress 2021

    Transcranial Magnetic Stimulation in Parkinsonism. Tremor and Biomechanics Evaluation

    D. Labunskiy, S. Kiryukhina, A. Hamed, N. Dzhalolitdinova, S. Abdulsahib (Saransk, Russian Federation)

    Objective: The aim of our study was to reveal the relationship between motor and muscle activity шт terms of plantar pressure distribution PPD) in Parkinson's…
  • MDS Virtual Congress 2021

    Challenges in Implementing Relevant Exercise Interventions in Mouse Models of Parkinson’s Disease

    D. Grogan, H. Skelton, J. Rubiano, C. Gutekunst, R. Gross (Augusta, USA)

    Objective: To determine the suitability of a motorized wheel as a forced exercise modality that does not rely on aversive stimuli for use in Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 389
  • 390
  • 391
  • 392
  • 393
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley